Ar
Non verificato

Arcus Biosciences

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieOncologiaSalute
18/11/2025
Eventi
Web e Social Network
Biotecnologia
Farmaceutica
Salute
Oncologia
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
1.00
31/10/2025
Finanza
Mercato azionario
Oncologia
Salute
HIV, AIDS e malattie autoimmuni
Sanità
Farmaceutica
Biotecnologia
Arcus Biosciences Announces Pricing of $250 Million Public Offering of Common Stock
1.00
30/10/2025
Mercato azionario
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Medicina - Varie
Arcus Biosciences Announces Commencement of Public Offering of Common Stock
1.00
28/10/2025
Mercato azionario
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Arcus Biosciences Reports Third-Quarter 2025 Financial Results and Provides a Pipeline Update
1.00
19/10/2025
Mercato del lavoro
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Taiho Pharmaceutical Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia
1.00
09/10/2025
Oncologia
Salute
Scienza
Farmaceutica
Biotecnologia
Mercato azionario
Finanza
Arcus Biosciences Announces New Employment Inducement Grants
1.00
06/10/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Web e Social Network
Industria
Eventi
Arcus Biosciences Presents New Data for its HIF-2a Inhibitor Casdatifan and Discloses First Inflammation Programs at Investor Event
1.00
24/09/2025
Mercato azionario
Finanza
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Arcus Biosciences Announces New Employment Inducement Grants
1.00
08/09/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Mercato azionario
Finanza
Arcus Biosciences Announces New Employment Inducement Grants
1.00
02/09/2025
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Web e Social Network
Eventi
Arcus Biosciences to Host Investor Event to Highlight its Late-Stage Casdatifan Program and Next Wave of Programs Focused on Inflammation
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0